A Review of DNA Methylation and microRNA Expression in Recurrent Pediatric Acute Leukemia

被引:19
作者
Hale, Victoria [1 ]
Hale, Gregory A. [1 ,2 ,3 ]
Brown, Patrick A. [2 ,3 ]
Amankwah, Ernest K. [1 ,2 ]
机构
[1] Johns Hopkins All Childrens Hosp, 501 6th Ave South, St Petersburg, FL 33701 USA
[2] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA
[3] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA
关键词
Pediatric leukemia; Epigenetics; Methylation; microRNA; Recurrence; ACUTE LYMPHOBLASTIC-LEUKEMIA; ACUTE MYELOID-LEUKEMIA; MINIMAL RESIDUAL DISEASE; POOR-PROGNOSIS; EPIGENETIC THERAPY; UP-REGULATION; CHILDHOOD; RELAPSE; CANCER; GENE;
D O I
10.1159/000452091
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Acute leukemia is the most common childhood cancer diagnosis and leading cause of cancer-related death among children and adolescents. Despite substantial improvements in the survival rate of childhood acute leukemia, approximately 20-40% of the patients who undergo treatment develop relapse, with a dismal one third of these patients surviving in the long term. Epigenetics plays an important role in the progression of cancer, and existing evidence suggests a role in childhood acute leukemia relapse. A better understanding of the epigenetic mechanisms in recurrent acute leukemia could potentially lead to novel therapeutic regimens to prevent or treat disease recurrences. In this review, we summarize existing evidence on two of the most studied epigenetic mechanisms, DNA methylation and microRNA expression, in recurrent pediatric acute leukemia. (C) 2016 S. Karger AG, Basel
引用
收藏
页码:61 / 67
页数:7
相关论文
共 60 条
[1]   Epigenetic Silencing of the Tumor Suppressor MicroRNA Hsa-miR-124a Regulates CDK6 Expression and Confers a Poor Prognosis in Acute Lymphoblastic Leukemia [J].
Agirre, Xabier ;
Vilas-Zornoza, Amaia ;
Jimenez-Velasco, Antonio ;
Ignacio Martin-Subero, Jose ;
Cordeu, Lucia ;
Garate, Leire ;
San Jose-Eneriz, Edurne ;
Abizanda, Gloria ;
Rodriguez-Otero, Paula ;
Fortes, Puri ;
Rifon, Jose ;
Bandres, Eva ;
Jose Calasanz, Maria ;
Martin, Vanesa ;
Heiniger, Anabel ;
Torres, Antonio ;
Siebert, Reiner ;
Roman-Gomez, Jose ;
Prosper, Felipe .
CANCER RESEARCH, 2009, 69 (10) :4443-4453
[2]  
Amankwah EK, 2012, TOXICOLOGY EPIGENETI
[3]   miR-21, miR-221 and miR-222 expression and prostate cancer recurrence among obese and non-obese cases [J].
Amankwah, Ernest K. ;
Anegbe, Evelyn ;
Park, Hyun ;
Pow-Sang, Julio ;
Hakam, Ardeshir ;
Park, Jong Y. .
ASIAN JOURNAL OF ANDROLOGY, 2013, 15 (02) :226-230
[4]   Upregulation of microRNA-100 predicts poor prognosis in patients with pediatric acute myeloid leukemia [J].
Bai, Jin ;
Guo, Aiping ;
Hong, Ze ;
Kuai, Wenxia .
ONCOTARGETS AND THERAPY, 2012, 5 :213-219
[5]   The role of diet and exercise in the transgenerational epigenetic landscape of T2DM [J].
Barres, Romain ;
Zierath, Juleen R. .
NATURE REVIEWS ENDOCRINOLOGY, 2016, 12 (08) :441-451
[6]   Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs [J].
Bartel, DP ;
Chen, CZ .
NATURE REVIEWS GENETICS, 2004, 5 (05) :396-400
[7]  
Batova A, 1997, CANCER RES, V57, P832
[8]   Relapsed childhood acute lymphoblastic leukaemia [J].
Bhojwani, Deepa ;
Pui, Ching-Hon .
LANCET ONCOLOGY, 2013, 14 (06) :E205-E217
[9]   Endogenous retroviruses and the human germline [J].
Bock, M ;
Stoye, JP .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2000, 10 (06) :651-655
[10]   DNA Methylation Adds Prognostic Value to Minimal Residual Disease Status in Pediatric T-Cell Acute Lymphoblastic Leukemia [J].
Borssen, Magnus ;
Haider, Zahra ;
Landfors, Mattias ;
Noren-Nystrom, Ulrika ;
Schmiegelow, Kjeld ;
Asberg, Ann E. ;
Kanerva, Jukka ;
Madsen, Hans O. ;
Marquart, Hanne ;
Heyman, Mats ;
Hultdin, Magnus ;
Roos, Goran ;
Forestier, Erik ;
Degerman, Sofie .
PEDIATRIC BLOOD & CANCER, 2016, 63 (07) :1185-1192